Alvotech (ALVO) Divestments (2024 - 2025)
Alvotech's (ALVO) quarterly Divestments came in at -$6.0 million in Q4 2025, down 140.41% on a YoY basis from $15.0 million in Q4 2024, and down 167.04% quarter-over-quarter from $9.0 million in Q3 2025.
Powered by 
Analysis
Alvotech (ALVO) Divestments (2024 - 2025) Analysis & Trends
Alvotech (ALVO) has reported Divestments for 2 consecutive years, with -$6.0 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Divestments fell 140.41% year-over-year to -$6.0 million; the trailing twelve-month figure through Dec 2025 stood at $5.9 million (changed N/A YoY), and the FY2025 full-year result was $5.9 million, down 50.42% from the prior year.
- Divestments declined to -$6.0 million in Q4 2025 per ALVO's latest filing, from $9.0 million in the prior quarter.
- Across five years, Divestments topped out at $15.0 million in Q4 2024 and bottomed at -$6.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 4.00 Mn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 52,813.79 |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -6.05 Mn |
| Sep 30, 2025 | 9.03 Mn |
| Mar 31, 2025 | 2.98 Mn |
| Dec 31, 2024 | 14.97 Mn |
| Sep 30, 2024 | -2.97 Mn |